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Metabolic syndrome (MetS) is a cluster of
metabolic risk factors for cardiovascular disease and
type 2 diabetes. It is also associated with  insulin
resistance (glucose intolerance) and obesity or
overweight1,2. According to the International
Diabetes Federation, a quarter of the world’s adult
population has MetS, and more cases are diagnosed
in males over 40 years of age1.
MetS occurs when a person has three or more
of the following measurements: (1) Abdominal
obesity - waist circumference of 40 inches or more
in men, and 35 inches or more in women; (2)
Triglyceride level of 150 milligrams per deciliter of
blood (mg/dL) or more; HDL cholesterol of less than
40 mg/dL in men or less than 50 mg/dL in
women;(3) Systolic blood pressure of 130mmHg
or greater, or diastolic blood pressure of 85mmHg
or greater; and (4) Fasting glucose of 100 mg/dL
or greater1,3.
There are increased risk for: Atherosclerosis,
Peripheral vascular disease, Coronary heart disease,
Heart attack, Stroke and Type 2 diabetes. The
National Cholesterol Education Program’s Adult
Treatment Panel III report (ATP III) identified the
proinflammatory state with elevations of C-reactive
protein and a prothrombotic state with increased
plasma plasminogen activator inhibitor and
fibrinogen as associated with the metabolic
syndrome4.
Many of the factors that contribute to
metabolic syndrome can be addressed through
lifestyle changes: balanced diet (maintaining a
healthy weight, reduce fat intake, change the
consumption of saturated fats to unsaturated fats,
increase the intake of fruits, vegetables, legumes
and whole grains and reduced intake of sugar) and
exercise (aerobic and muscle strengthening). The
World Health Organization recommends 30 minutes
of activity at least five times a week1,2,4,5.
Promising results of an important study
published in the BMC Public Heatlh6 was The Study
Cardiovascular Risk in Adolescents entitled “ERICA”.
This study aimed to estimate the prevalence of
cardiovascular risk factors including metabolic
syndrome in adolescents aged 12 to 17 years in
Brazilian cities with over 100,000 inhabitants. We
collected about 85,000 adolescents. The participants
answered a questionnaire on demographic
characteristics and lifestyle (physical activity,
smoking, alcohol), mental disorders, reproductive
and oral health, and blood samples for fasting
glucose, total cholesterol, HDL-cholesterol, LDL -
cholesterol, triglycerides, and glycated hemoglobin.
It is expected that with the data from “ERICA” able
to contribute to the knowledge about risk factors
for atherosclerosis, obesity, diabetes mellitus among
adolescents and serve to support the development
of health policies
ATP III recommended first-line therapy the
increased physical activity. The studies with exercise
have increased in the scientific literature, between
these studies autonomic modulation in patients with
metabolic syndrome and exercise have risen too5,7.
The heart autonomic modulation can be measured
noninvasively, this process is known the analysis of
heart rate variability (HRV)8. HRV can be used to
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estimate autonomic nervous control of the
cardiovascular system and reduced HRV significantly
increases cardiovascular mortality9.
There is strong evidence that obesity leads to
increased sympathetic modulation and a decreased
vagal tone leading to a lack of autonomic control
(characterized by reduction of heart rate variability)
that can bring about changes in the renin-
angiotensin-aldosterone system in alpha agonists
and central alpha 2-1 and beta-adrenergic receptors.
In addition, changes in plasma catecholamines and
increased muscle sympathetic nerve activity are
important characteristics in obese individuals8,9,10.
All these factors contribute further to increased blood
pressure11,12,13.
Souza et al14 have reviewed studies of HRV in
obese children,and find that obese children have
lower activity of the parasympathetheticnervous
system. In addition,8-13 there is evidence showing
that interventions such as diet and physical activity
can promote improvements in autonomic nervous
system balance in this population.
Vanderlei et al15,16,17 showed autonomic
dysfunction characterized by reduced sympathetic
modulation in obese children. The RRTri, TINN,
SDNN, RMSSD, pNN50, SD1, SD2, LF and HF indices
were lower among the obese children when
compared to the eutrophic group.
Vanderlei, Vanderlei and Garner18, in an
elegant study in this issue of JGDH publish important
contribution in the area of HRV. This is the article
“Heart rate dynamics by novel chaotic globals to
HRV in obese Youths” which is innovative evaluation
of obese youth by chaotic behavior of HRV. Time
heart rate series can be studied by means of
statistical methods, this article studies the dynamic
point of view, combining the nonlinear deterministic
systems (chaotic behavior). Eighty-six young people
were distributed in two groups (obese and control).
The results illustrate that there is great variation in
both the mean values and standard deviation for
both young non-obese and obese, there is an
increase in the chaotic response when going from
non-obese to young obese, thus showing that the
youth obesity increases the chaotic response.
Stuckey et al10 systematically reviewed
associations between heart rate variability and
metabolic syndrome. Fourteen studies were
included. Heart rate variability generally was reduced
in women with metabolic syndrome compared to
those without, while results in men were
inconsistent. Time and frequency domain heart rate
variability parameters were associated with
individual metabolic syndrome risk factors, though
sex differences exist. The authors concluded HRV is
altered differently in men and women with metabolic
syndrome.
Stuckey et al19 evaluated whether an 8-week
exercise intervention would improve MetS risk
factors and HRV in a population with MetS risk
factors. The waist circumference and diastolic BP
were reduced and maximal oxygen uptake (VO2max)
increased. Low frequency (LF) was reduced and high
frequency (HF) was increased, Thus, exercise
intervention improved MetS risk factors and HRV
parameters, but only changes in systolic BP were
associated with improved autonomic function.
Koskinenet al20 associated the presence of the
MetS with lower HF and LF in men and women, and
with higher LF/HF ratio in women. In young men,
waist circumference was the strongest individual
MetS component that associated with HRV. After
adjustments for age and heart rate, MetS was
associated with lower HF and higher LF/HF ratio in
women.
Jarczoket al21 recruited 2441 study participants
and affirmed a negative correlation between HRV
and glycemic status that appeared to be almost
linear in a large cohort of healthy workers. Liao et
al22examined the association between the level of
cardiac autonomic activity and MetS disorders. HRV
indices were significantly lower in individuals with
MetS. An increase in fasting insulin was associated
with 88% higher odds of having a lower HF. The
pattern of associations was similar for LF and SDNN.
In recent years HRV has been an important
instrument to evaluate autonomic modulation. The
association of HRV indices with appropriate forms
of exercise prescription can raise awareness for
better treatment of patients with metabolic
syndrome. MetS presented alterations in the
autonomic nervous system, characterized by
decreases in parasympathetic activity and global
HRV, but the reduction in sympathetic modulation
is not entirely clear. HRV analysis by chaotic behavior
can bring an advance for evaluation and treatment
of obese, diabetic, hypertensive and metabolic
syndrome.
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